• HOME
  • ABOUT US
    • People >
      • Management
      • CCSB Staff >
        • Research Fellows
        • Graduate Students
        • Research Staff
      • Core Members
      • Alumni
    • Photo Gallery
    • Join us
  • RESEARCH
    • Interactome Mapping
    • Generation of ORFeome resources
    • Human Isoform Project
    • Network Perturbations >
      • Systematic platform for the edgetic study of protein biophysical interactions
      • Viral Network Perturbations
      • Drug Screening and Druggability of the Interactome
    • Collaborations
  • PUBLICATIONS
    • Pivotal
    • Recent
    • By Year >
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • All In PubMed
  • RESOURCES
    • Interactome Data
    • ORFeomes >
      • Human 8.1
      • C. elegans 3.1
    • Links >
      • CCSB CEGS
      • FuncBase
      • Genome Space
      • Genome Web
      • GTEx
      • NCBI - Gene
      • NHGRI CEGS
      • ORFeome Collaboration
      • UCSC - Gene Browser
    • Lab intranet
  • NEWS & EVENTS
  • CONTACT US
CCSB - Center for Cancer Systems Biology

Graduate Students


Picture

 Georges Coppin
  Visiting Graduate Student

  education
  BSc, Université Libre de Bruxelles, 2014
  MSc, Université Libre de Bruxelles, 2016


  contact Info
  Georges_Coppin@dfci.harvard.edu



Since the human genome was first sequenced in 2003, the number of available sequenced genomes has exploded, resulting in identification of a plethora of genetic variants. But linking genotype and phenotype, already a non-trivial task, is further complicated as most of these variants are rare and hence lack the statistical power required to perform phenotypic association. As a result, there is a massive effort in the scientific community to come up with orthogonal methodologies to annotate the functional consequence of these variants, in a high-throughput manner. A large number of tools are available that assess the deleteriousness of these rare variants. However, they rely on existing information like known disease-association or conservation to predict the negative effect of these variants, a
nd hence are liable to misinterpretation. In addition, since most of the high-throughput methodologies simply predict the negative impact of variants, they provide little information about the underlying disease biology.
We are interested in understanding the pathogenicity of these variants, and their molecular implications, by studying their impact on unbiased, comprehensive biophysical networks like the binary protein-protein interactome. In the last decade, several protein networks have been released, each of which provide unique insights into various biological processes. Integrating these with other quantitative molecular estimates like expression levels will help us understand the cellular dynamics in a systematic manner. Moreover, we will experimentally generate thousands of alleles carrying different disease variants, and compare their interaction profiles with reference alleles to understand how perturbations of networks can result in different disease pathologies.



Picture
 Florent Laval
  Visiting Graduate Student

 education
 BSc, Université de Liège, Belgium, 2015
 MSc, Université de Liège, Belgium, 2017
 PhD, Université de Liège, Belgium, present


  contact Info
  Florent_Laval@dfci.harvard.edu




Traditional forward and reverse genetic approaches have considered genes as discrete units of function for decades. Null mutations and gene deletions provide an understanding of phenotypes that result from the complete absence of gene products. Most diseases, however, stem from single nucleotide polymorphisms, suggesting that gene deletions do not accurately reflect the molecular mechanisms that underlie human disorders. Furthermore, the polygenic regulation of biological functions that are mediated through complex networks of biophysical interactions emphasizes the importance of investigating these interactions in greater depth. Accordingly, efforts to create comprehensive biophysical interaction or “interactome” networks by systematically mapping all protein-protein interactions in the cell have been a major research focus. While these reference interactome maps provide a valuable resource for the study of protein function, such interaction networks merely represent static snapshots of complex macromolecule assemblies, lacking textured information regarding their dynamics or context-dependent functions. Furthermore, these reference maps fall short of describing the impact of interaction perturbations, as subtle dysfunctions within a network resulting from gene mutation can potentially result in major systemic consequences. Besides, the complete loss of a gene product does not necessarily lead to the same phenotypic outcome as an interaction-specific or edge-specific or “edgetic” perturbation of a protein-protein interaction. While gene knockout approaches are convenient for describing the impact of gross disruptions in organisms, an edge-centered approach can dissect the complexities of biological systems. It therefore follows that a requirement for understanding these biological systems is the consideration of each individual interaction within a network. This emphasizes the importance of developing a higher resolution genetic approach that focuses on gene products as interacting entities.
My graduate project thus aims to devise a systematic platform to dissect interactions within protein networks by using a mutagenic approach with a yeast complex involved in transcriptional repression as a model.



HOME | ABOUT US | RESEARCH | PUBLICATIONS| RESOURCES| NEWS & EVENTS | CONTACT US 
©2021 Center for Cancer Systems Biology Dana-Farber Cancer Institute